Featured Articles
-
Translation Of RNA Medicines From Design To Clinic
3/2/2022
Understand the advantages and challenges of lipid-based delivery systems for successful translation of RNA into clinical development.
-
Accelerating The Development And Scale-Up Of mRNA Vaccines
3/2/2022
Learn how downstream considerations can make the difference between success and failure on the path towards the commercialization of mRNA vaccines.
-
Genomic Medicine And The Tools To Realize Its Potential
1/12/2022
New technologies and collaborations driving the democratization of RNA therapeutics are creating an explosion of opportunity for companies pursuing the development of these transformative medicines.
-
Key Insights Into Overcoming mRNA Process Challenges
9/8/2021
Realizing the potential of mRNA requires focus on key areas and strategies that could help alleviate the bottlenecks in this growing market segment.
-
mRNA Manufacturing Workflow
6/2/2021
Therapies based on messenger RNA, such as mRNA vaccines, have revolutionary potential. Learn more about key objectives, considerations, and strategies in mRNA manufacturing.
-
Automating Cell Therapy Manufacturing For GMP Compliance And Consistency
11/1/2019
Exploring the use of automation in cell therapy and advanced therapeutic medicinal product manufacturing to improve safety, quality, and compliance is a key factor in advancing patient care.
-
GMP Cell Therapy Manufacturing: How And When To Get Started
5/2/2019
As hospitals and translational facilities explore implementation, they concurrently evaluate whether or not to manufacture the therapies onsite. Here is a guideline of how and when to get started.
-
Cell Therapy Manufacturing: The Supply Chain Challenge
4/1/2019
Overcoming the challenges of manufacturing and administering a complex product to any patient is critical for delivering cell therapies. Two industry experts detail strategies to meet supply chain challenges.
-
Oligonucleotide Manufacturing: Take Control Of Your Process
What do you need to know before you take your process in-house? A team of experts on nucleic acids therapeutics outlined five key things for you to consider as you make the change.
-
Add mRNA Capacity — Flexibly
Learn about a platform that addresses five critical pain points to help mRNA manufacturers flexibly scale while improving the digital maturity of their sites.